Global Afatinib Dimaleate Supply, Demand and Key Producers, 2024-2030
Page: 119
Published Date: 11 Feb 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The global Afatinib Dimaleate market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
In recent years, Alfatinib maleate has become a highly anticipated topic in the field of cancer. As a targeted therapeutic drug, it can help control the spread and growth of many cancers, such as non-small cell lung cancer, breast cancer, liver cancer, kidney cancer, stomach cancer, colorectal cancer, etc.
As a second-generation drug, afatinib maleate has good development prospects. For patients, afatinib maleate provides them with more and better treatment options; For pharmaceutical companies, afatinib maleate is a potential best-selling product worth developing.
Afatinib dimaleate is an oral molecular targeted drug developed and produced by Boehringer Ingelheim, Germany. It is a TKIs with strong and irreversible dual inhibitory effect on EGFR and HER2, and was approved by THE US FDA in July 2013.It is not only suitable for first-line treatment of metastatic NSCLC with EGFR exon 19 deletion mutation or exon 21 (L858R) replacement mutation, but also a second - and third-line target drug for egFR-TKIS resistance.
This report studies the global Afatinib Dimaleate production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Afatinib Dimaleate, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Afatinib Dimaleate that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Afatinib Dimaleate total production and demand, 2019-2030, (K Units)
Global Afatinib Dimaleate total production value, 2019-2030, (USD Million)
Global Afatinib Dimaleate production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Afatinib Dimaleate consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Afatinib Dimaleate domestic production, consumption, key domestic manufacturers and share
Global Afatinib Dimaleate production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Afatinib Dimaleate production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Afatinib Dimaleate production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Afatinib Dimaleate market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Kelun－Kazpharm, Qilu Pharmaceutical, Boehringer-Ingelheim, CSPC Pharmaceutical, Merck, Hansoh Pharmaceuticak, Beacon Pharmaceuticals, Qingfeng Medicine Group and Yangtze River Pharm, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Afatinib Dimaleate market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Afatinib Dimaleate Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Afatinib Dimaleate Market, Segmentation by Type
20 mg
30 mg
40 mg
Global Afatinib Dimaleate Market, Segmentation by Application
Hospital
Clinic
Companies Profiled:
Kelun－Kazpharm
Qilu Pharmaceutical
Boehringer-Ingelheim
CSPC Pharmaceutical
Merck
Hansoh Pharmaceuticak
Beacon Pharmaceuticals
Qingfeng Medicine Group
Yangtze River Pharm
Chia Tai-Tianqing
Key Questions Answered
1. How big is the global Afatinib Dimaleate market?
2. What is the demand of the global Afatinib Dimaleate market?
3. What is the year over year growth of the global Afatinib Dimaleate market?
4. What is the production and production value of the global Afatinib Dimaleate market?
5. Who are the key producers in the global Afatinib Dimaleate market?
Table of Contents
1 Supply Summary
1.1 Afatinib Dimaleate Introduction
1.2 World Afatinib Dimaleate Supply & Forecast
1.2.1 World Afatinib Dimaleate Production Value (2019 & 2023 & 2030)
1.2.2 World Afatinib Dimaleate Production (2019-2030)
1.2.3 World Afatinib Dimaleate Pricing Trends (2019-2030)
1.3 World Afatinib Dimaleate Production by Region (Based on Production Site)
1.3.1 World Afatinib Dimaleate Production Value by Region (2019-2030)
1.3.2 World Afatinib Dimaleate Production by Region (2019-2030)
1.3.3 World Afatinib Dimaleate Average Price by Region (2019-2030)
1.3.4 Europe Afatinib Dimaleate Production (2019-2030)
1.3.5 China Afatinib Dimaleate Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Afatinib Dimaleate Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Afatinib Dimaleate Major Market Trends
2.1 World Afatinib Dimaleate Demand (2019-2030)
2.2 World Afatinib Dimaleate Consumption by Region
2.2.1 World Afatinib Dimaleate Consumption by Region (2019-2024)
2.2.2 World Afatinib Dimaleate Consumption Forecast by Region (2025-2030)
2.3 United States Afatinib Dimaleate Consumption (2019-2030)
2.4 China Afatinib Dimaleate Consumption (2019-2030)
2.5 Europe Afatinib Dimaleate Consumption (2019-2030)
2.6 Japan Afatinib Dimaleate Consumption (2019-2030)
2.7 South Korea Afatinib Dimaleate Consumption (2019-2030)
2.8 ASEAN Afatinib Dimaleate Consumption (2019-2030)
2.9 India Afatinib Dimaleate Consumption (2019-2030)
3.1 World Afatinib Dimaleate Production Value by Manufacturer (2019-2024)
3.2 World Afatinib Dimaleate Production by Manufacturer (2019-2024)
3.3 World Afatinib Dimaleate Average Price by Manufacturer (2019-2024)
3.4 Afatinib Dimaleate Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Afatinib Dimaleate Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Afatinib Dimaleate in 2023
3.5.3 Global Concentration Ratios (CR8) for Afatinib Dimaleate in 2023
3.6 Afatinib Dimaleate Market: Overall Company Footprint Analysis
3.6.1 Afatinib Dimaleate Market: Region Footprint
3.6.2 Afatinib Dimaleate Market: Company Product Type Footprint
3.6.3 Afatinib Dimaleate Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4.1 United States VS China: Afatinib Dimaleate Production Value Comparison
4.1.1 United States VS China: Afatinib Dimaleate Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Afatinib Dimaleate Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Afatinib Dimaleate Production Comparison
4.2.1 United States VS China: Afatinib Dimaleate Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Afatinib Dimaleate Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Afatinib Dimaleate Consumption Comparison
4.3.1 United States VS China: Afatinib Dimaleate Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Afatinib Dimaleate Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Afatinib Dimaleate Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Afatinib Dimaleate Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Afatinib Dimaleate Production Value (2019-2024)
4.4.3 United States Based Manufacturers Afatinib Dimaleate Production (2019-2024)
4.5 China Based Afatinib Dimaleate Manufacturers and Market Share
4.5.1 China Based Afatinib Dimaleate Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Afatinib Dimaleate Production Value (2019-2024)
4.5.3 China Based Manufacturers Afatinib Dimaleate Production (2019-2024)
4.6 Rest of World Based Afatinib Dimaleate Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Afatinib Dimaleate Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Afatinib Dimaleate Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Afatinib Dimaleate Production (2019-2024)
5.1 World Afatinib Dimaleate Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 20 mg
5.2.2 30 mg
5.2.3 40 mg
5.3 Market Segment by Type
5.3.1 World Afatinib Dimaleate Production by Type (2019-2030)
5.3.2 World Afatinib Dimaleate Production Value by Type (2019-2030)
5.3.3 World Afatinib Dimaleate Average Price by Type (2019-2030)
6.1 World Afatinib Dimaleate Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Afatinib Dimaleate Production by Application (2019-2030)
6.3.2 World Afatinib Dimaleate Production Value by Application (2019-2030)
6.3.3 World Afatinib Dimaleate Average Price by Application (2019-2030)
7.1 Kelun－Kazpharm
7.1.1 Kelun－Kazpharm Details
7.1.2 Kelun－Kazpharm Major Business
7.1.3 Kelun－Kazpharm Afatinib Dimaleate Product and Services
7.1.4 Kelun－Kazpharm Afatinib Dimaleate Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Kelun－Kazpharm Recent Developments/Updates
7.1.6 Kelun－Kazpharm Competitive Strengths & Weaknesses
7.2 Qilu Pharmaceutical
7.2.1 Qilu Pharmaceutical Details
7.2.2 Qilu Pharmaceutical Major Business
7.2.3 Qilu Pharmaceutical Afatinib Dimaleate Product and Services
7.2.4 Qilu Pharmaceutical Afatinib Dimaleate Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Qilu Pharmaceutical Recent Developments/Updates
7.2.6 Qilu Pharmaceutical Competitive Strengths & Weaknesses
7.3 Boehringer-Ingelheim
7.3.1 Boehringer-Ingelheim Details
7.3.2 Boehringer-Ingelheim Major Business
7.3.3 Boehringer-Ingelheim Afatinib Dimaleate Product and Services
7.3.4 Boehringer-Ingelheim Afatinib Dimaleate Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Boehringer-Ingelheim Recent Developments/Updates
7.3.6 Boehringer-Ingelheim Competitive Strengths & Weaknesses
7.4 CSPC Pharmaceutical
7.4.1 CSPC Pharmaceutical Details
7.4.2 CSPC Pharmaceutical Major Business
7.4.3 CSPC Pharmaceutical Afatinib Dimaleate Product and Services
7.4.4 CSPC Pharmaceutical Afatinib Dimaleate Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 CSPC Pharmaceutical Recent Developments/Updates
7.4.6 CSPC Pharmaceutical Competitive Strengths & Weaknesses
7.5 Merck
7.5.1 Merck Details
7.5.2 Merck Major Business
7.5.3 Merck Afatinib Dimaleate Product and Services
7.5.4 Merck Afatinib Dimaleate Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Merck Recent Developments/Updates
7.5.6 Merck Competitive Strengths & Weaknesses
7.6 Hansoh Pharmaceuticak
7.6.1 Hansoh Pharmaceuticak Details
7.6.2 Hansoh Pharmaceuticak Major Business
7.6.3 Hansoh Pharmaceuticak Afatinib Dimaleate Product and Services
7.6.4 Hansoh Pharmaceuticak Afatinib Dimaleate Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Hansoh Pharmaceuticak Recent Developments/Updates
7.6.6 Hansoh Pharmaceuticak Competitive Strengths & Weaknesses
7.7 Beacon Pharmaceuticals
7.7.1 Beacon Pharmaceuticals Details
7.7.2 Beacon Pharmaceuticals Major Business
7.7.3 Beacon Pharmaceuticals Afatinib Dimaleate Product and Services
7.7.4 Beacon Pharmaceuticals Afatinib Dimaleate Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Beacon Pharmaceuticals Recent Developments/Updates
7.7.6 Beacon Pharmaceuticals Competitive Strengths & Weaknesses
7.8 Qingfeng Medicine Group
7.8.1 Qingfeng Medicine Group Details
7.8.2 Qingfeng Medicine Group Major Business
7.8.3 Qingfeng Medicine Group Afatinib Dimaleate Product and Services
7.8.4 Qingfeng Medicine Group Afatinib Dimaleate Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Qingfeng Medicine Group Recent Developments/Updates
7.8.6 Qingfeng Medicine Group Competitive Strengths & Weaknesses
7.9 Yangtze River Pharm
7.9.1 Yangtze River Pharm Details
7.9.2 Yangtze River Pharm Major Business
7.9.3 Yangtze River Pharm Afatinib Dimaleate Product and Services
7.9.4 Yangtze River Pharm Afatinib Dimaleate Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Yangtze River Pharm Recent Developments/Updates
7.9.6 Yangtze River Pharm Competitive Strengths & Weaknesses
7.10 Chia Tai-Tianqing
7.10.1 Chia Tai-Tianqing Details
7.10.2 Chia Tai-Tianqing Major Business
7.10.3 Chia Tai-Tianqing Afatinib Dimaleate Product and Services
7.10.4 Chia Tai-Tianqing Afatinib Dimaleate Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Chia Tai-Tianqing Recent Developments/Updates
7.10.6 Chia Tai-Tianqing Competitive Strengths & Weaknesses
8.1 Afatinib Dimaleate Industry Chain
8.2 Afatinib Dimaleate Upstream Analysis
8.2.1 Afatinib Dimaleate Core Raw Materials
8.2.2 Main Manufacturers of Afatinib Dimaleate Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Afatinib Dimaleate Production Mode
8.6 Afatinib Dimaleate Procurement Model
8.7 Afatinib Dimaleate Industry Sales Model and Sales Channels
8.7.1 Afatinib Dimaleate Sales Model
8.7.2 Afatinib Dimaleate Typical Customers
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Afatinib Dimaleate Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Afatinib Dimaleate Production Value by Region (2019-2024) & (USD Million)
Table 3. World Afatinib Dimaleate Production Value by Region (2025-2030) & (USD Million)
Table 4. World Afatinib Dimaleate Production Value Market Share by Region (2019-2024)
Table 5. World Afatinib Dimaleate Production Value Market Share by Region (2025-2030)
Table 6. World Afatinib Dimaleate Production by Region (2019-2024) & (K Units)
Table 7. World Afatinib Dimaleate Production by Region (2025-2030) & (K Units)
Table 8. World Afatinib Dimaleate Production Market Share by Region (2019-2024)
Table 9. World Afatinib Dimaleate Production Market Share by Region (2025-2030)
Table 10. World Afatinib Dimaleate Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Afatinib Dimaleate Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Afatinib Dimaleate Major Market Trends
Table 13. World Afatinib Dimaleate Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Afatinib Dimaleate Consumption by Region (2019-2024) & (K Units)
Table 15. World Afatinib Dimaleate Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Afatinib Dimaleate Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Afatinib Dimaleate Producers in 2023
Table 18. World Afatinib Dimaleate Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Afatinib Dimaleate Producers in 2023
Table 20. World Afatinib Dimaleate Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Afatinib Dimaleate Company Evaluation Quadrant
Table 22. World Afatinib Dimaleate Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Afatinib Dimaleate Production Site of Key Manufacturer
Table 24. Afatinib Dimaleate Market: Company Product Type Footprint
Table 25. Afatinib Dimaleate Market: Company Product Application Footprint
Table 26. Afatinib Dimaleate Competitive Factors
Table 27. Afatinib Dimaleate New Entrant and Capacity Expansion Plans
Table 28. Afatinib Dimaleate Mergers & Acquisitions Activity
Table 29. United States VS China Afatinib Dimaleate Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Afatinib Dimaleate Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Afatinib Dimaleate Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Afatinib Dimaleate Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Afatinib Dimaleate Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Afatinib Dimaleate Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Afatinib Dimaleate Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Afatinib Dimaleate Production Market Share (2019-2024)
Table 37. China Based Afatinib Dimaleate Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Afatinib Dimaleate Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Afatinib Dimaleate Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Afatinib Dimaleate Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Afatinib Dimaleate Production Market Share (2019-2024)
Table 42. Rest of World Based Afatinib Dimaleate Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Afatinib Dimaleate Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Afatinib Dimaleate Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Afatinib Dimaleate Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Afatinib Dimaleate Production Market Share (2019-2024)
Table 47. World Afatinib Dimaleate Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Afatinib Dimaleate Production by Type (2019-2024) & (K Units)
Table 49. World Afatinib Dimaleate Production by Type (2025-2030) & (K Units)
Table 50. World Afatinib Dimaleate Production Value by Type (2019-2024) & (USD Million)
Table 51. World Afatinib Dimaleate Production Value by Type (2025-2030) & (USD Million)
Table 52. World Afatinib Dimaleate Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Afatinib Dimaleate Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Afatinib Dimaleate Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Afatinib Dimaleate Production by Application (2019-2024) & (K Units)
Table 56. World Afatinib Dimaleate Production by Application (2025-2030) & (K Units)
Table 57. World Afatinib Dimaleate Production Value by Application (2019-2024) & (USD Million)
Table 58. World Afatinib Dimaleate Production Value by Application (2025-2030) & (USD Million)
Table 59. World Afatinib Dimaleate Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Afatinib Dimaleate Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Kelun－Kazpharm Basic Information, Manufacturing Base and Competitors
Table 62. Kelun－Kazpharm Major Business
Table 63. Kelun－Kazpharm Afatinib Dimaleate Product and Services
Table 64. Kelun－Kazpharm Afatinib Dimaleate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Kelun－Kazpharm Recent Developments/Updates
Table 66. Kelun－Kazpharm Competitive Strengths & Weaknesses
Table 67. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Qilu Pharmaceutical Major Business
Table 69. Qilu Pharmaceutical Afatinib Dimaleate Product and Services
Table 70. Qilu Pharmaceutical Afatinib Dimaleate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Qilu Pharmaceutical Recent Developments/Updates
Table 72. Qilu Pharmaceutical Competitive Strengths & Weaknesses
Table 73. Boehringer-Ingelheim Basic Information, Manufacturing Base and Competitors
Table 74. Boehringer-Ingelheim Major Business
Table 75. Boehringer-Ingelheim Afatinib Dimaleate Product and Services
Table 76. Boehringer-Ingelheim Afatinib Dimaleate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Boehringer-Ingelheim Recent Developments/Updates
Table 78. Boehringer-Ingelheim Competitive Strengths & Weaknesses
Table 79. CSPC Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 80. CSPC Pharmaceutical Major Business
Table 81. CSPC Pharmaceutical Afatinib Dimaleate Product and Services
Table 82. CSPC Pharmaceutical Afatinib Dimaleate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. CSPC Pharmaceutical Recent Developments/Updates
Table 84. CSPC Pharmaceutical Competitive Strengths & Weaknesses
Table 85. Merck Basic Information, Manufacturing Base and Competitors
Table 86. Merck Major Business
Table 87. Merck Afatinib Dimaleate Product and Services
Table 88. Merck Afatinib Dimaleate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Merck Recent Developments/Updates
Table 90. Merck Competitive Strengths & Weaknesses
Table 91. Hansoh Pharmaceuticak Basic Information, Manufacturing Base and Competitors
Table 92. Hansoh Pharmaceuticak Major Business
Table 93. Hansoh Pharmaceuticak Afatinib Dimaleate Product and Services
Table 94. Hansoh Pharmaceuticak Afatinib Dimaleate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Hansoh Pharmaceuticak Recent Developments/Updates
Table 96. Hansoh Pharmaceuticak Competitive Strengths & Weaknesses
Table 97. Beacon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 98. Beacon Pharmaceuticals Major Business
Table 99. Beacon Pharmaceuticals Afatinib Dimaleate Product and Services
Table 100. Beacon Pharmaceuticals Afatinib Dimaleate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Beacon Pharmaceuticals Recent Developments/Updates
Table 102. Beacon Pharmaceuticals Competitive Strengths & Weaknesses
Table 103. Qingfeng Medicine Group Basic Information, Manufacturing Base and Competitors
Table 104. Qingfeng Medicine Group Major Business
Table 105. Qingfeng Medicine Group Afatinib Dimaleate Product and Services
Table 106. Qingfeng Medicine Group Afatinib Dimaleate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Qingfeng Medicine Group Recent Developments/Updates
Table 108. Qingfeng Medicine Group Competitive Strengths & Weaknesses
Table 109. Yangtze River Pharm Basic Information, Manufacturing Base and Competitors
Table 110. Yangtze River Pharm Major Business
Table 111. Yangtze River Pharm Afatinib Dimaleate Product and Services
Table 112. Yangtze River Pharm Afatinib Dimaleate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Yangtze River Pharm Recent Developments/Updates
Table 114. Chia Tai-Tianqing Basic Information, Manufacturing Base and Competitors
Table 115. Chia Tai-Tianqing Major Business
Table 116. Chia Tai-Tianqing Afatinib Dimaleate Product and Services
Table 117. Chia Tai-Tianqing Afatinib Dimaleate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 118. Global Key Players of Afatinib Dimaleate Upstream (Raw Materials)
Table 119. Afatinib Dimaleate Typical Customers
Table 120. Afatinib Dimaleate Typical Distributors
List of Figure
Figure 1. Afatinib Dimaleate Picture
Figure 2. World Afatinib Dimaleate Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Afatinib Dimaleate Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Afatinib Dimaleate Production (2019-2030) & (K Units)
Figure 5. World Afatinib Dimaleate Average Price (2019-2030) & (US$/Unit)
Figure 6. World Afatinib Dimaleate Production Value Market Share by Region (2019-2030)
Figure 7. World Afatinib Dimaleate Production Market Share by Region (2019-2030)
Figure 8. Europe Afatinib Dimaleate Production (2019-2030) & (K Units)
Figure 9. China Afatinib Dimaleate Production (2019-2030) & (K Units)
Figure 10. Afatinib Dimaleate Market Drivers
Figure 11. Factors Affecting Demand
Figure 12. World Afatinib Dimaleate Consumption (2019-2030) & (K Units)
Figure 13. World Afatinib Dimaleate Consumption Market Share by Region (2019-2030)
Figure 14. United States Afatinib Dimaleate Consumption (2019-2030) & (K Units)
Figure 15. China Afatinib Dimaleate Consumption (2019-2030) & (K Units)
Figure 16. Europe Afatinib Dimaleate Consumption (2019-2030) & (K Units)
Figure 17. Japan Afatinib Dimaleate Consumption (2019-2030) & (K Units)
Figure 18. South Korea Afatinib Dimaleate Consumption (2019-2030) & (K Units)
Figure 19. ASEAN Afatinib Dimaleate Consumption (2019-2030) & (K Units)
Figure 20. India Afatinib Dimaleate Consumption (2019-2030) & (K Units)
Figure 21. Producer Shipments of Afatinib Dimaleate by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 22. Global Four-firm Concentration Ratios (CR4) for Afatinib Dimaleate Markets in 2023
Figure 23. Global Four-firm Concentration Ratios (CR8) for Afatinib Dimaleate Markets in 2023
Figure 24. United States VS China: Afatinib Dimaleate Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 25. United States VS China: Afatinib Dimaleate Production Market Share Comparison (2019 & 2023 & 2030)
Figure 26. United States VS China: Afatinib Dimaleate Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States Based Manufacturers Afatinib Dimaleate Production Market Share 2023
Figure 28. China Based Manufacturers Afatinib Dimaleate Production Market Share 2023
Figure 29. Rest of World Based Manufacturers Afatinib Dimaleate Production Market Share 2023
Figure 30. World Afatinib Dimaleate Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 31. World Afatinib Dimaleate Production Value Market Share by Type in 2023
Figure 32. 20 mg
Figure 33. 30 mg
Figure 34. 40 mg
Figure 35. World Afatinib Dimaleate Production Market Share by Type (2019-2030)
Figure 36. World Afatinib Dimaleate Production Value Market Share by Type (2019-2030)
Figure 37. World Afatinib Dimaleate Average Price by Type (2019-2030) & (US$/Unit)
Figure 38. World Afatinib Dimaleate Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 39. World Afatinib Dimaleate Production Value Market Share by Application in 2023
Figure 40. Hospital
Figure 41. Clinic
Figure 42. World Afatinib Dimaleate Production Market Share by Application (2019-2030)
Figure 43. World Afatinib Dimaleate Production Value Market Share by Application (2019-2030)
Figure 44. World Afatinib Dimaleate Average Price by Application (2019-2030) & (US$/Unit)
Figure 45. Afatinib Dimaleate Industry Chain
Figure 46. Afatinib Dimaleate Procurement Model
Figure 47. Afatinib Dimaleate Sales Model
Figure 48. Afatinib Dimaleate Sales Channels, Direct Sales, and Distribution
Figure 49. Methodology
Figure 50. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Kelun－Kazpharm Qilu Pharmaceutical Boehringer-Ingelheim CSPC Pharmaceutical Merck Hansoh Pharmaceuticak Beacon Pharmaceuticals Qingfeng Medicine Group Yangtze River Pharm Chia Tai-Tianqing
Related Reports
11 Jan 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
